https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-09-12 / J Extracell Vesicles 2013;2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-09-12 / J Extracell Vesicles 2013;22013-09-12 00:00:002013-09-12 00:00:00Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-09-11 / Mol. Cancer 2013 Sep;12(1):103
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-09-11 / Mol. Cancer 2013 Sep;12(1):1032013-09-11 00:00:002019-02-15 09:22:36Oncolytic viruses as therapeutic cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-142013-09-01 00:00:002019-02-15 08:39:14Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-09-01 / Anticancer Res. 2013 Sep;33(9):3855-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-09-01 / Anticancer Res. 2013 Sep;33(9):3855-92013-09-01 00:00:002021-11-15 14:43:00Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-19 / Anat Rec (Hoboken) 2013 Oct;296(10):1552-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-19 / Anat Rec (Hoboken) 2013 Oct;296(10):1552-602013-08-19 00:00:002019-02-15 09:21:27TRAIL is involved in the tumoricidal activity of mouse natural killer cells stimulated by Newcastle disease virus in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-482013-08-14 00:00:002021-11-15 14:43:30Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-13 / Cryobiology 2013 Oct;67(2):235-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-13 / Cryobiology 2013 Oct;67(2):235-402013-08-13 00:00:002019-02-15 08:45:41Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-03 / Arch. Gynecol. Obstet. 2014 Jan;289(1):155-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-03 / Arch. Gynecol. Obstet. 2014 Jan;289(1):155-622013-08-03 00:00:002019-02-15 08:45:49In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-01 / Scand. J. Immunol. 2013 Aug;78(2):167-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-01 / Scand. J. Immunol. 2013 Aug;78(2):167-712013-08-01 00:00:002019-02-15 08:39:49Current status and future perspectives of dendritic cell-based cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-92013-08-01 00:00:002019-02-15 08:50:01Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium
